Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company's ...

Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated with gene ...

Salanersen, which is designed for once-yearly dosing, is a potential successor to Biogen's blockbuster SMA drug Spinraza, which generated worldwide sales of nearly $1.55 billion last year and requires ...

Brain atrophy tends to begin in your 30s and 40s, but certain lifestyle changes can slow or even reverse shrinkage.

Six weeks of resistance training with a new wearable device more than doubled spinal muscular atrophy patients' leg strength, ...

Muscle atrophy, as the name suggests, is a weakening or reduction of muscle due to lack of use or due to a disease. It is a result of a mismatch between the rates of protein synthesis and protein ...

Ancient bacteria that have evolved to become integral to our cells—converting nutrients from food into energy—may also contribute to neurologic disorders, such as spinal muscular atrophy (SMA) and ...

Alzheimer's disease begins to weave a web in the brain and remodel neuronal tissue 15 to 20 years before the first symptoms appear. From the time this happens, however, until the disease is diagnosed ...

Muscle atrophy refers to the gradual wasting or loss of muscle tissue, leading to a reduction in muscle mass and strength. This condition can result from various factors, including inactivity, aging, ...

Panel A shows how insulin and insulin-like growth factor-1 (IGF-1) effect protein anabolism by signaling through their receptors (IR and IGF1R, respectively). This signaling results in the activation ...